Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome.
chemotherapy
diarrhea
microbiome
supportive care
tyrosine kinase inhibitors
Journal
Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834
Informations de publication
Date de publication:
Historique:
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
19
8
2021
Statut:
ppublish
Résumé
Small molecule receptor tyrosine kinase inhibitors (SM-TKIs) are among a group of targeted cancer therapies, intended to be more specific to cancer cells compared with treatments, such as chemotherapy, hence reducing adverse events. Unfortunately, many patients report high levels of diarrhea, the pathogenesis of which remains under investigation. In this article, we compare the current state of knowledge of the pathogenesis of chemotherapy-induced diarrhea (CID) in comparison to SM-TKI-induced diarrhea, and investigate how a similar research approach in both areas may be beneficial. To this end, we review evidence that both treatment modalities may interact with the gut microbiome, and as such the microbiome should be investigated for its ability to reduce the risk of diarrhea.
Identifiants
pubmed: 32493068
doi: 10.1177/1534735420928493
pmc: PMC7273583
doi:
Substances chimiques
Antineoplastic Agents
0
Protein Kinase Inhibitors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1534735420928493Références
Mol Cancer. 2018 Feb 19;17(1):29
pubmed: 29455654
Endocrine. 2017 Apr;56(1):121-128
pubmed: 28155175
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
Cancer Chemother Pharmacol. 2016 Nov;78(5):881-893
pubmed: 27590709
Oral Microbiol Immunol. 2003 Oct;18(5):278-84
pubmed: 12930518
J Clin Oncol. 2013 Dec 20;31(36):4504-11
pubmed: 24248687
J Clin Oncol. 2007 May 1;25(13):1670-6
pubmed: 17470860
Oral Dis. 2010 Oct;16(7):597-600
pubmed: 20846150
Thyroid. 2017 Nov 27;:
pubmed: 29048237
Case Rep Cardiol. 2016;2016:5040176
pubmed: 27547470
Gastroenterology. 2000 Jun;118(6):1106-16
pubmed: 10833485
Nat Rev Cancer. 2004 Apr;4(4):277-84
pubmed: 15057287
BMC Cancer. 2019 Jun 3;19(1):533
pubmed: 31159765
Ann Oncol. 2016 Nov;27(11):2137-2138
pubmed: 27502719
Expert Opin Drug Metab Toxicol. 2019 Dec;15(12):993-1004
pubmed: 31794273
Clin Genitourin Cancer. 2018 Oct;16(5):365-368
pubmed: 29858123
Eur J Cancer. 2006 Mar;42(4):548-56
pubmed: 16426838
Oncology. 2013;84(1):6-13
pubmed: 23075905
J Clin Oncol. 2010 Feb 20;28(6):1061-8
pubmed: 20100962
Expert Rev Anticancer Ther. 2016;16(4):383-90
pubmed: 26943236
Adv Cancer Res. 2008;100:35-83
pubmed: 18620092
Expert Opin Pharmacother. 2018 Dec;19(18):2055-2062
pubmed: 30392436
Discov Med. 2013 Mar;15(82):166-76
pubmed: 23545045
Clin Infect Dis. 2009 Jul 15;49(2):262-70
pubmed: 19514856
Int J Cancer. 2017 Jun 15;140(12):2820-2829
pubmed: 28316082
Curr Opin Support Palliat Care. 2018 Jun;12(2):187-197
pubmed: 29547491
PLoS One. 2018 Dec 6;13(12):e0208171
pubmed: 30521551
Support Care Cancer. 2019 Oct;27(10):4023-4033
pubmed: 31286231
Curr Oncol. 2010 Jul;17 Suppl 1:S18-30
pubmed: 20680104
Lancet Oncol. 2016 Mar;17(3):367-377
pubmed: 26874901
Pharmacoeconomics. 2013 Sep;31(9):753-66
pubmed: 23963867
Curr Opin Support Palliat Care. 2017 Jun;11(2):125-132
pubmed: 28333867
Onco Targets Ther. 2016 Jun 20;9:3621-31
pubmed: 27382300
Cancer Chemother Pharmacol. 2019 Mar;83(3):531-543
pubmed: 30535958
Front Pharmacol. 2016 Nov 03;7:414
pubmed: 27857691
Cancer Chemother Pharmacol. 2012 Jul;70(1):191-9
pubmed: 22418773
Support Care Cancer. 2013 Jul;21(7):1843-52
pubmed: 23397098
Inflamm Bowel Dis. 2018 Aug 16;24(9):1926-1940
pubmed: 29796620
Gut Microbes. 2012 May-Jun;3(3):250-60
pubmed: 22614705
J Nutr. 2010 Jan;140(1):7-11
pubmed: 19889806
Curr Opin Support Palliat Care. 2009 Mar;3(1):31-5
pubmed: 19365159
PLoS One. 2013;8(1):e55128
pubmed: 23383079
Br J Pharmacol. 2014 May;171(9):2335-50
pubmed: 24428790
Cancer. 2014 May 15;120(10):1453-61
pubmed: 24615748
Curr Opin Support Palliat Care. 2013 Jun;7(2):162-7
pubmed: 23399616
Expert Rev Anticancer Ther. 2017 Aug;17(8):669-679
pubmed: 28649882
Medicine (Baltimore). 2019 Aug;98(31):e16392
pubmed: 31374006
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30668547
J Immunother Cancer. 2019 Nov 6;7(1):287
pubmed: 31694714
PLoS One. 2012;7(7):e39764
pubmed: 22844397
N Engl J Med. 2015 Apr 30;372(18):1689-99
pubmed: 25923549
Dig Dis Sci. 2013 Mar;58(3):668-77
pubmed: 23329012
Cancer Treat Rev. 2014 Aug;40(7):883-91
pubmed: 24867380
Support Care Cancer. 2004 Apr;12(4):219-26
pubmed: 14767748
EJC Suppl. 2013 Sep;11(2):172-91
pubmed: 26217127
J Thorac Oncol. 2010 Sep;5(9):1477-80
pubmed: 20736807
PLoS One. 2013;8(1):e54788
pubmed: 23382968
Clin Lung Cancer. 2006 Mar;7(5):326-31
pubmed: 16640804
Ann Oncol. 2016 Nov;27(11):2138-2139
pubmed: 27664149
EBioMedicine. 2019 Jun;44:730-740
pubmed: 30940601
Oncologist. 2007 Dec;12(12):1443-55
pubmed: 18165622
Gynecol Oncol. 2018 Jul;150(1):173-179
pubmed: 29627080
Int J Mol Sci. 2014 Aug 08;15(8):13768-801
pubmed: 25110867
J Clin Oncol. 2004 Nov 1;22(21):4410-7
pubmed: 15514383
Arch Histol Cytol. 1998 Mar;61(1):17-28
pubmed: 9557964
Complement Ther Med. 2015 Jun;23(3):356-62
pubmed: 26051570
Curr Opin Support Palliat Care. 2016 Jun;10(2):152-6
pubmed: 27035390
Mol Cancer Ther. 2016 Jun;15(6):1376-86
pubmed: 27197307
Ther Adv Med Oncol. 2010 Jan;2(1):51-63
pubmed: 21789126
Curr Treat Options Gastroenterol. 2019 Mar;17(1):115-126
pubmed: 30661163
Oncol Lett. 2019 Sep;18(3):2677-2683
pubmed: 31404289
Oncologist. 2018 Mar;23(3):306-315
pubmed: 29146618
Best Pract Res Clin Gastroenterol. 2009;23(1):113-24
pubmed: 19258191
Curr Oncol. 2014 Dec;21(6):329-36
pubmed: 25489260
J Surg Res. 2002 Jun 1;105(1):25-30
pubmed: 12069497
Science. 2012 Apr 27;336(6080):489-93
pubmed: 22442383
Cancer Manag Res. 2018 Jul 19;10:2141-2150
pubmed: 30050324
Clin Breast Cancer. 2017 Feb;17(1):76-78
pubmed: 27692565
PLoS Pathog. 2020 Jan 21;16(1):e1008251
pubmed: 31961914
Lancet. 2016 Mar 12;387(10023):1066-1074
pubmed: 27025186
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H560-76
pubmed: 16172168
Cancer Chemother Pharmacol. 2020 Apr;85(4):793-803
pubmed: 32060615
Lung Cancer. 2015 Apr;88(1):74-9
pubmed: 25704957
Scientifica (Cairo). 2014;2014:194185
pubmed: 25126444
Int J Cancer. 2014 Aug 15;135(4):763-73
pubmed: 24127298
Int J Cancer. 2019 May 15;144(10):2365-2376
pubmed: 30155890
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Ann Oncol. 2016 Sep;27(9):1712-8
pubmed: 27287210
J Clin Invest. 1999 Aug;104(3):253-62
pubmed: 10430606
Mol Cancer. 2018 Feb 19;17(1):36
pubmed: 29455664
Genes Cells. 2013 Feb;18(2):110-22
pubmed: 23279183
Ann Oncol. 2007 May;18(5):817-26
pubmed: 17030544
Cancer Chemother Pharmacol. 2014 Sep;74(3):617-27
pubmed: 25055934
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):356-365
pubmed: 28270698
Cancer Biol Ther. 2008 Dec;7(12):1919-25
pubmed: 18927500
Sci Rep. 2018 Apr 18;8(1):6219
pubmed: 29670191
Int J Cancer. 2016 Feb 1;138(3):540-54
pubmed: 25716346
Nat Rev Gastroenterol Hepatol. 2015 Aug;12(8):446-57
pubmed: 26122478
Breast Cancer Res Treat. 2019 May;175(1):5-15
pubmed: 30671765
Clin Cancer Res. 2015 Dec 1;21(23):5286-93
pubmed: 26152743
Int J Exp Pathol. 2009 Oct;90(5):489-99
pubmed: 19765103
Lancet. 2011 Dec 3;378(9807):1931-9
pubmed: 22056247
Clin Gastroenterol Hepatol. 2020 Mar 24;:
pubmed: 32220613
Am J Pathol. 2014 Jul;184(7):2023-34
pubmed: 24952429
Nat Clin Pract Oncol. 2008 May;5(5):268-78
pubmed: 18349858
Oncotarget. 2018 Dec 28;9(102):37662-37675
pubmed: 30701022
Cancer Treat Rev. 2015 Jul;41(7):646-52
pubmed: 26073491
J Support Oncol. 2004 Jan-Feb;2(1):21-32; discussion 35-6
pubmed: 15330370
J Clin Oncol. 2010 Mar 10;28(8):1351-7
pubmed: 20142600
J Med Econ. 2016 Sep;19(9):900-12
pubmed: 27123564
Onco Targets Ther. 2018 Oct 02;11:6405-6414
pubmed: 30323618